DTC

Willow2002_

What squeeze it has a low DTC and a low SI

Dapper-Attempt-5029

Haha so tired of posters here claiming their “research “ of 0.03 DTC with 22% S I & borrow fee rates at 45…. Yes…! Prepare for another GAMESTOP!!! Sometimes the research is excellent, but what people believe qualifies as a potential short squeeze or as a short squeeze, case in point is sadly I suppose ignorance. When you lose all of your wife’s beer, money in the stock market, it’s not gonna be a pretty Saturday night… peace, and profits, my friends

CorvetteCole

I guess for me I don't understand why so many people seem to think... - SpaceX DTC V2 won't be competitive. - ASTS will beat SpaceX to market for broadband direct to phones (especially since SpaceX has the benefit of having learned how to run the current generation). Like we say oh SpaceX DTC started with just SMS and that's mostly true, but it actually already provides LTE to phones right now. It's not anywhere near what we're expecting out of next gen tech... but they already have experience doing this! Plus, I don't think anyone would argue against SpaceX's obvious proficiency with phased arrays. I want ASTS to succeed, but for me I've been skeptical about the sheer amount of hype on them. They've got a tough battle ahead of them, I don't think SpaceX is going to be easy competition at all.

Illustrious_Mood_274

The Fintel data for S-O-U-N provides a clear, data-backed confirmation that the Inventory Trap is tightening exactly as established in the Matts Stonks framework. Here is what the indicators on that page are telling us about the current setup: 1. The Debt: Short Interest & Float The official Nasdaq short interest stands at 134,908,585 shares, which is a massive 35.34% of the float. This confirms that over a third of the company's equity is tied up in a short obligation that must eventually be repaid. With a Days to Cover (DTC) ratio of 4.01 to 4.89, the exit for these shorts is not just a door—it’s a pinhole. 2. The Ammo: Short Shares Availability The "Black Slice" is running on fumes. While availability fluctuates intraday, the data shows frequent drops to the 80,000 - 100,000 share range. This confirms that the borrowable inventory is functionally exhausted. Even when blocks of 300k+ appear, they are often immediately "absorbed" by the mechanical defense patterns of the whales. 3. The Rent: Spiking Borrow Fees This is the most aggressive indicator on the page. The short borrow fee has surged to 7.07% (up from 1.90% just a week ago). • The Squeeze Context: This doubling of the "Daily Rent" puts immense capital pressure on short sellers. They are paying a premium just to hold their positions while the price floor remains defended by the whales. 4. The Invisible War: Off-Exchange Short Volume The Off-Exchange Short Volume Ratio is sitting at 60.42%. This is the data-driven proof of the HFT Churn. More than half of the shorting activity is happening in dark pools and off-exchange venues, which is where the "Wash Trading" and "Spoof Walls" are used to pin the price and hide the true demand from the lit market. 5. Mechanical Trigger: Gamma Squeeze Score Fintel identifies a high Gamma Squeeze Score, highlighting the risk to market makers. With significant open interest at the $9.00 strike, the $9.01 Strategic Objective remains the primary mechanical tripwire. Hitting that level would force market makers to compete with short sellers for that tiny pool of available shares. The Verdict The Fintel data confirms the Matts Stonks thesis: the shorts are out of bullets, the rent is rising, and the plumbing is dry. The mechanical advantage remains with the retail investor who understands these indicators. The Strategy Remains: Buy, Hold, and Turn Off Share Lending to keep shrinking that Black Slice.

Flipslips

Yes, you can now use data/video on Starlink DTC (limited speeds of course), but their upgraded satellites will offer 150mbps to cell devices.

Flipslips

ASTS doesn’t even have operational service yet while starlink has millions of DTC users

Flipslips

Do you think SpaceX will just never innovate again? They just revealed plans for their new DTC sats the other day: https://news.satnews.com/2026/02/25/spacex-unveils-150mbps-performance-target-for-upgraded-direct-to-cell-starlink/

Dirk_Breakiron

The thing is they already have a full DTC constellation that works. “The cell phone signal you have with you is better than the one you left at home” And yes, it is a first gen product but you’re smoking crack if you l think they don’t have a V3 version in the works and will likely get it deployed nearly the same time AST becomes operational. SpaceX has experience operating constellations and ground infrastructure, proven they can scale and launch rapidly and own their own launch giving them an unrivaled edge on cost and speed. AST tech is better than gen 1 on paper - but SpaceX leads everywhere that matters right now.

eternalmortal

That's a complete misunderstanding of ASTS satellite capabilities. As described, their Bluebird 6 satellites will have 10 Ghz of processing bandwidth capacity, while a Starlink satellite has reportedly 2 Ghz capacity, but thousands upon thousands of satellites currently in orbit. So Starlink needs about 5 satellites for every 1 ASTS satellite. ASTS's advantage is only in DTC tech. They will still need a more robust network of satellites to handle the same amount of data.

eternalmortal

ASTS tech is different than Starlink, but it's also *way* behind on coverage. they only have a handful of satellites up compared to almost 10,000 Starlink satellites. Even if DTC is better they simply cannot handle the potential bandwidth of demand with what they have in orbit, or even what they're planning to put in orbit by 2030. Not only that, but if/when Starlink does crack DTC in the same way, they have an internal company rocket delivery system that can get thousands of DTC capable satellites up faster than ASTS could get hundreds. They also have the licensing for the thousands of rockets, while ASTS does not. Their tech advantage is not as wide a moat as Starlink's logistics and coverage advantage.

iwasshotbyatigeronce

The whole Square thing is funny. Now it puts pressure on highly diverse companies (Software + DTC Retail) like AMZN with MILLIONS of employees. They will never be able to reach operating margins that can compete with what future expectations may look like.

The_Insider_Edge

or they havent gotten DTC yet and are waiting for that

Complex_Aardvark_661

I think the real question isn't growth vs value, it's pricing power vs no pricing power. when the consumer pulls back, the companies that can raise prices without losing customers are gonna be totally fine. the ones that can't are gonna get crushed regardless of what label you put on them. Like Costco can probably push through modest price increases because people are locked into that membership and the value prop is still there. but a random DTC brand with no switching costs? good luck. I've been trying to audit my portfolio the same way honestly. looking at each position and asking "if inflation stays sticky and consumers keep tightening, can this company actually pass costs through?" and if the answer is no or maybe, that's a problem. what's frustrating is there's no great way to screen for pricing power, it's more of a qualitative thing you have to research company by company. anyone found a good shortcut for that?

GeoLogic23

A couple hemp beverage companies announced expansion news for Texas today. Bayou City Hemp has been partnered with 8th Wonder Brewery for a while. Bayou City announced a [funding round to support expansion](https://www.prnewswire.com/news-releases/bayou-city-hemp-launches-funding-round-to-fuel-200-growth-and-dominate-30b-thc-beverage-boom-with-retail-powerhouse-edge-302691205.html). >BCH's **three-tier distribution** model, leveraging established wine, spirits, and beer networks, provides a sustainable edge over DTC-focused competitors, enabling scalable growth amid regulatory shifts. >Operating in 15 states with 27 distributors, BCH is expanding to 40 in 2026, including **MillerCoors network partnerships covering \~80% of Texas**. Multi-year exclusive venue deals with **White Oak Music Hall and ten additional nationwide locations** underscore BCH's mainstream traction. >....selling over 2.5 million products in 2025, with **99% through three-tier distribution** and over 40% on-premise Cann also announced they are now being carried throughout [Spec's locations in Texas](https://www.businesswire.com/news/home/20260218606895/en/Canns-Social-Tonics-Hit-More-Texas-Shelves-Specs-Wine-Spirits-Finer-Foods-To-Carry-Full-Product-Assortment). >Cann....today announced a major retail partnership with Spec's Wine, Spirits & Finer Foods, the largest beverage retailer in Texas. Spec's and Cann are both on the Coalition for Adult Beverage Alternatives, which is the hemp beverage advocacy group whose [largest member is Tilray](https://www.prnewswire.com/news-releases/new-coalition-advocates-for-safe-legal-thc-beverages-302278212.html). I think venue partnerships like RYM at the United Center and Bayou City at White Oak are going to be a big part of the hemp beverage market. Major sports/music venue company Oak View Group has been pursuing hemp beverages for years, having partnered with Green Monke and Cookies. Trump also recently pardoned the co-founder of Oak View Group for rigging an Arena bid in Texas.

Super-Activity-4675

I'd love to see some updated dates on the shares short. Fidelity is still showing numbers for 1/30. Something is off with the DTC because that should have popped seriously in early Feb and instead it dropped. Regardless with this much short interest, it's basically a powder keg.

redditr79

Respect the breakdown, it’s solid on paper. I agree it’s not a textbook 2021-style, 30% SI, 8-day DTC squeeze setup. Fair. But here’s where I disagree 👇 Squeezes in small caps rarely happen because a spreadsheet says “20%+ SI.” They happen because of liquidity imbalance + catalyst + momentum. A few facts: • 5–6% SI in a thin, volatile name can still create sharp upside when volume expands. • 1.3 DTC is based on average volume. If volume triples on news, that metric becomes meaningless in real time. • 45% borrow isn’t trivial, even if it’s down from 65%, that’s still expensive positioning. On dilution 🤝 yes, offerings increase float. But the recent raises also boosted cash significantly and cleaned up parts of the balance sheet. That changes the fundamental narrative. It’s not just “more shares,” it’s more runway. I’m not arguing for a guaranteed mega squeeze. I’m saying: • Earnings just hit • Q2 will reflect acquisition impact • Margin restoration underway • Technical levels are tightening In a low-attention name, that combo can trigger sharp upside, squeeze or not. It doesn’t need 20% SI to move from $1s to $3–$5 on momentum. Call it volatility with catalysts. Not fantasy.

redditr79

I get what you’re saying, textbook squeeze setups usually have 20%+ SI, tiny float, 3+ DTC. Agree. But small caps don’t always move off a checklist. 5% SI and 1.3 DTC are based on averages. If volume shifts hard around earnings or a contract drop, that math changes fast. In thinner names, price can rip 30–50% before “DTC” even matters. Shorts react to tape pressure, not spreadsheets. I’m not calling it a guaranteed mega squeeze. I’m saying with: • Earnings + acquisition impact • Margin improvement narrative • Backlog/contract potential • A clean technical break …it doesn’t need 20% SI to run to $3–$5. Not GME. Just a volatile small cap with catalysts. That’s all. Peace. ✌️ GL!

Dapper-Attempt-5029

5% & 1.3 DTC actually really does disqualify it. I wouldn’t call it a low float either. Just my opinion but you need to be realistic. If shorts can cover in 1 day at normal trading volume… No squeeze. If the float was 1 million shares… even then, but the float is 8X larger than that & short interest is less than 500,000 shares. The amount of shares available to short interest pic are just amount available from 1 broker. You need as a matter of basis at least 20% short interest, a float under 2 million and DTC over 3 & that’s where it might start. Ask Grok brother. I’d bet my leg this will not squeeze. Sorry- good luck. Peace & profits.

NavyDean

TBH, the DTC gas been heavily reformed towards wall street since 2008, so if a crash happens causing an ownership challenge in shares. Yes, wall street can claim your shares, if the shares they sold you don't have any backing, after they internally settle. Have to remember that most brokers just sell you an IOU of a share, not an actual share.

the_beer-baron

Honestly the author gives me SovCit vibes with his focus on the DTC as some shadowy company. Plus, discussing retirement funds without touching on ERISA is missing some obvious safeguards regarding rehypothecation.

the_beer-baron

Do some of your own research rather than take an opinion piece at face value from someone shilling their book and has an axe to grind with the DTC (borderline SovCit stuff). One aspect he does not discuss at all is ERISA and its impact on rehypothecation and PTs.

winpickles4life

Just saying their DTC satellites suck compared to AST, in several important ways. Calm down.

_Ukey_

You're correct about the pop but that was from 1/27 to 1/29. This short interest data appears to be as of 1/30. So please correct me if I'm misinterpreting, but the setup is still there. I'm lightly in but the reason i'm not going in heavy is the low DTC.

Astrocoder

Yes it does. It wont squeeze with DTC that low

skinnyjoints

Definitely. But there’s only 1 million shares outstanding so that’s pretty much guaranteed. With SI this high, DTC doesn’t matter nearly as much.

East-Description-243

That’s just the start ASTS lovers. I’m holding long dated puts for when they are go bankrupt. 10 satellites this year if you’re lucky and then it’ll be too late. Starlink and Amazon are gonna figure out DTC long before Asts gets enough coverage to matter.

_hiddenscout

$RL Q3/2026 Revenue: $2.41B vs. $2.22B est. EPS: $6.22 vs. $5.32 est. Ralph Lauren reports Q3 FY2026 results ahead of expectations and raises the full-year constant-currency revenue and operating margin expansion outlook. Direct-to-consumer momentum remains strong—2.1 million new customers, AUR up 18%, DTC comps up in the high-single digits, with Asia leading growth (Asia up 22%); wholesale grew double-digits. Margins expanded, the balance sheet stays robust with $2.3 billion in cash, and roughly $500 million has been returned to shareholders year-to-date.

Willow2002_

So from what I’m seeing you’re more talking about a low float volatility play because there’s decently high volume in the stock compared to SI = low DTC. But what you’re more focused on is the float being small, probs due to insider ownership being so high. But yeah I see this as something that could jump up. Do you know of any catalysts that could set stuff off a bit.

plasticbug

Ultimately, you are trusting DTC, and the fact federal government will not allow it to fail.

The_Insider_Edge

Will turn up with DTC, they just got OTCQB give it a week

Inevitable_Fuel7244

Depends on the specific product/business we're working with but speaking generally if you were to invest money this is the order you would do it: 1. Meta (FB/IG) 2. Google Ads (search/shopping) 3. YouTube Ads You can basically run a brand making over $100 mil a year in rev off those channels alone. Most brands never need to grow beyond that mix. It's the trifecta. Works for your homies shitty little clothing startup, works for big DTC brands like hexclad etc. Those channels are often also paired with working with some influencers either small or large to help produce ad content. From there it really depends on the brand and our strategy but thats when we'd start to look at: 4. TikTok 5. Bing 6. Traditional TV (brand dependent) 7. Direct mailers (brand dependent) Then from there is when we might start to look at Reddit lol.

The_Insider_Edge

They need DTC then the volume will come quickly

94ChevyCavalier

Don’t sleep on $PDYN Quick data points to look at indicating short term volatility and indications that the squeeze is actually yet to happen-  JAN 28-70 million in volume  Combined volume of preceding 3 months was less than that one day  Short interest since then flat at 22%  Short borrow fee was steady at around 4 and through the end of the week rocketed to 40  Average trading volume is 3 million making actual DTC closer to 3 days and rising Seller pressure has lost momentum but shorts are still entrenched with virtually no price change between Tuesdays close and Friday’s close Engage with this stock. A squeeze is likely with proper engagement and interest.  The company has a 2 year runway, and will be revising estimates higher, earnings will be a major catalyst. I intend to hold long but near term this is highly attractive. Someone, likely institutional, is betting hard on PDYN to decline. I don’t like people who bet the DONT line when I’m on the table. I do, however like the stock.

Wimea

I'm on my phone so excuse the formatting. Which broker is this? I've seen this fee when attempting to buy stocks that cannot be settled by US DTC. If the stock is not sponsored through any of the major US exchanges then a broker would have to manually do it hence the fee. Best you call your brokerage and ask.

hab365

Yeah, and most of SpaceX’s value comes from Starlink rather than from launch and they’re having more and more competition there, whether it be internet or DTC

Changeuplife

ASBP- Agreement signed, low float, high shorts and over 25 DTC. Another sqeeze potential. Just bought in

Changeuplife

DCX - VERY low float, high shorts with over 12 DTC! News and volume huge! Let's make a run on this...EVERYONE

IndividualNo7155

What’s the SI and DTC tho? Can’t find it

Changeuplife

GRI - News, float under 1M, high short % and DTC over 4. We could push this quite high! Buy the dip

Changeuplife

HIND - News, massive volume over 90 days, only 3M float and DTC 2.64. Coming down from its highs, buy on the dip. Might wait until open to pounce on this one.

Changeuplife

mbai - news with massive volume and DTC almost 6, low float. Buy the dip

Changeuplife

Not a penny but check out LE. Great news, low float, volume increasing and DTC shorts is 9 days! This could be a good entry point for a couple day play! Wait for the open to see where it lands and find a comfortable entry point.

Changeuplife

Not seeing it! Good news, yes, but very low volume on this news and no potential for any sqeeze. DTC .15. Maybe longer term hold.

zhabesha

Maybe that’s why they are moving away from DTC to insurance?

RedPlumpTomato

Enjoy my AI Slop Analysis! CYCU - Cycurion, Inc. / Information Technology Services | United States | $8.9M Market Cap Technology QUICK STATS Price: $2.46 | Float: 2.4M (nano-float) Day: -3.53% | Week: -9.56% | Month: -14.58% 52w: $2.11 - $323.87 (currently -99% from high) ATH: $323.87 (down 99%) IPO: Feb 2025 (11 months old) BULL THESIS Cybersecurity company with recent $1.1M contract win. Analyst target $7.00 (+185% upside). Nano-float (2.4M) means any volume could move it significantly. Trading near 52w low ($2.11) - could be bottoming. BEAR THESIS Down 99% from ATH - classic pump and dump pattern. Massive dilution (+572% shares outstanding). Serial diluter with 6 offerings in 1 year. Burning cash (-111% profit margin). Very low institutional interest (2.8%). All timeframes negative. Volume dying. FUNDAMENTALS Debt/Equity: 0.59x (moderate) Short Interest: 11.3% (2.4 DTC) Institutional: 2.8% (very low) Profit Margin: -111% (burning cash) Analyst Target: $7.00 (+185% upside, 1 analyst) RED FLAGS \- Shares +572% (extreme dilution) \- Serial diluter: 6 offerings in 1 year \- Down 99% from ATH \- Volume dying (0.1x average) \- All timeframes negative CHART: BEARISH (-35 pts) Falling knife pattern. 6-month downtrend (-79%). Volume dying. THESIS HEALTH: BROKEN (0/100) \- 2 negative headlines \- 7 positive headlines \- Recent: Won $1.1M contract but stock still falling SEC STATUS: CAUTION Serial diluter with 6 offerings in past year. VERDICT: AVOID High risk. Down 99% from ATH with massive dilution history. All timeframes bleeding. Very low institutional interest. The $1.1M contract win is noise - fundamentals are broken. LEVELS Support: $2.11 (52w low / ATL) Resistance: $3.50 (recent) Not financial advice. DYOR.

RedPlumpTomato

My AI Slop Analysis! LEXX - Lexaria Bioscience Corp Healthcare/Biotech | Canada | $21M Market Cap QUICK STATS Price: $0.85 | Float: 23.5M Month: +52% | Week: +12% | Day: +4% 52w: $0.46 - $1.91 (currently -56% from high) ATH: $12.50 (down 93%) BULL THESIS Biotech with patented drug delivery technology (DehydraTECH). Phase trials ongoing. Analysts see 4-5x upside. Nano-float (23.5M) means any volume spike could move price significantly. Recent momentum (+52% month) suggests accumulation may be starting. BEAR THESIS Serial diluter - 8 offerings in one year, shares up 27%. Down 93% from ATH. Very low institutional interest (7%) - smart money not buying. Shelf registration active means more dilution likely coming. Could be a value trap. FUNDAMENTALS Debt/Equity: 0.02x (healthy) Short Interest: 6.7% (low, 1.2 DTC) Institutional: 7.1% (very low) Analyst Target: $4.50 (+429% upside, 3 analysts) RED FLAGS \- Serial diluter: 8 offerings in past year \- Shares +27% (dilution) \- Shelf registration active \- Down 93% from ATH CHART: BEARISH Falling knife pattern. Recent +52% spike may be late entry. SENTIMENT Minimal discussion. First mentioned Dec 2025 at $1.34, now -37%. VERDICT: NEUTRAL No clear edge. Momentum is there (+52% month) but dilution history is concerning. Very low institutional backing. If entering, small size with tight stop. LEVELS Support: $0.46 (52w low) Resistance: $1.91 (52w high) Not financial advice. DYOR.

RedPlumpTomato

My AI Slop Analysis **LEXX - Lexaria Bioscience Corp** Healthcare/Biotech | Canada | $21M Market Cap **Quick Stats** Price: $0.85 | Float: 23.5M Month: +52% | Week: +12% | Day: +4% 52w: $0.46 - $1.91 (currently -56% from high) ATH: $12.50 (down 93%) **Bull Thesis** Biotech with patented drug delivery technology (DehydraTECH). Phase trials ongoing. Analysts see 4-5x upside. Nano-float (23.5M) means any volume spike could move price significantly. Recent momentum (+52% month) suggests accumulation may be starting. **Bear Thesis** Serial diluter - 8 offerings in one year, shares up 27%. Down 93% from ATH. Very low institutional interest (7%) - smart money not buying. Shelf registration active means more dilution likely coming. Could be a value trap. **Fundamentals** Debt/Equity: 0.02x (healthy) Short Interest: 6.7% (low, 1.2 DTC) Institutional: 7.1% (very low) Analyst Target: $4.50 (+429% upside, 3 analysts) **Red Flags** Serial diluter: 8 offerings in past year Shares +27% (dilution) Shelf registration active Down 93% from ATH **Chart: Bearish** Falling knife pattern. Recent +52% spike may be late entry. **Sentiment** Minimal discussion. First mentioned Dec 2025 at $1.34, now -37%. **Verdict: Neutral** No clear edge. Momentum is there (+52% month) but dilution history is concerning. Very low institutional backing. If entering, small size with tight stop.

RedPlumpTomato

# LEXX - Lexaria Bioscience Corp **Healthcare/Biotech | Canada | $21M Market Cap** ## Quick Stats - Price: $0.85 | Float: 23.5M - Month: +52% | Week: +12% | Day: +4% - 52w: $0.46 - $1.91 (currently -56% from high) - ATH: $12.50 (down 93%) ## Fundamentals - Debt/Equity: 0.02x (healthy) - Short Interest: 6.7% (low, 1.2 DTC) - Institutional: 7.1% (very low) - Analyst Target: $4.50 (+429% upside, 3 analysts) ## Red Flags - Serial diluter: 8 offerings in past year - Shares +27% (dilution) - Shelf registration active - Down 93% from ATH ## Chart: Bearish - Falling knife pattern - Recent +52% spike may be late entry ## Sentiment - Minimal discussion (1 post in 7 days) - First mentioned Dec 2025 at $1.34, now -37% ## Verdict: Neutral No clear edge. Momentum is there (+52% month) but dilution history is concerning. Very low institutional backing. If entering, small size with tight stop. ## Levels - Support: $0.46 (52w low) - Resistance: $1.91 (52w high) *Not financial advice. DYOR.* My AI Slop Analysis!

RedPlumpTomato

# LEXX - Lexaria Bioscience Corp **Healthcare/Biotech | Canada | $21M Market Cap** ## Quick Stats - Price: $0.85 | Float: 23.5M - Month: +52% | Week: +12% | Day: +4% - 52w: $0.46 - $1.91 (currently -56% from high) - ATH: $12.50 (down 93%) ## Fundamentals - Debt/Equity: 0.02x (healthy) - Short Interest: 6.7% (low, 1.2 DTC) - Institutional: 7.1% (very low) - Analyst Target: $4.50 (+429% upside, 3 analysts) ## Red Flags - Serial diluter: 8 offerings in past year - Shares +27% (dilution) - Shelf registration active - Down 93% from ATH ## Chart: Bearish - Falling knife pattern - Recent +52% spike may be late entry ## Sentiment - Minimal discussion (1 post in 7 days) - First mentioned Dec 2025 at $1.34, now -37% ## Verdict: Neutral No clear edge. Momentum is there (+52% month) but dilution history is concerning. Very low institutional backing. If entering, small size with tight stop. ## Levels - Support: $0.46 (52w low) - Resistance: $1.91 (52w high) *Not financial advice. DYOR.* Here is my AI Slop Analysis!

Murky-Pin7299

So what numbers are we potentially looking at? Trading at $1.30 right now on IBKR. Today’s range 1.19-1.46. Volume 650k. Shortable shares 53,700. Days to cover 0.3. DTC too low to squeeze just yet.

ryzetard

and as I mentioned earlier DTC just plummeted to \~1 so any covering theoritically takes one day so not much of a squeeze can happen.

ryzetard

where do you see this short interest and DTC? i keep asking yet no one is able to respond. Are you all aware of the reverse split on it or not?

theoldme3

The stock market should work on simple supply and demand. Not some algorithm controlled by shit bags who are already rich. It has been manipulated for way too long and FINRA, SEC, DTC, DTCC and all those other bull shit, alphabet named regulators, are in on it.

ryzetard

i know you are hyped but just think critically for a moment. the latest DTC/SI data is for 31st December as per Nasdaq itself. Look at the recent volume spike and ask yourself - how much more liquid is this stock now considering that.

its-me__

DTC is interesting but i agrees FTD and borrow rate both are not that bullish

CanadianSneakerNut

Yahoo is fine, but upgrading your data sources is a game‑changer. I’m a big TradingView fan — didn’t realize how much I was missing until I grabbed it on a Black Friday deal. The data is cleaner, deeper, and way easier to work with. FIGS’ slowest YoY growth was 2024 → 2025, but even in a rough economy they still managed +1.8% revenue. Quarterly breakdown for 2025 tells the real story: soft Q1, strong Q2 rebound, and net margins improving every quarter through Q3. Balance sheet is solid too. Cash + equivalents almost cover total debt, and both short‑ and long‑term assets comfortably outweigh liabilities. There’s way more to this story than just the P/E ratio. FIGS is a niche brand with a loyal customer base, strong DTC economics, and a balance sheet that gives them room to operate. They’re not growing hyper‑fast anymore, but they’re executing well in a tough retail environment. Momentum traders might not love the slower growth, but fundamentally this isn’t the kind of company I’d be lining up to bet against. I wouldn’t open a massive position at current levels, but calling FIGS a short just because the P/E looks high feels like surface‑level analysis.

skinnyjoints

DTC is sitting at 7 currently. You are right though. The float is tiny so any volume is going to drop the days to cover to near zero. But the tiny float is going to make it difficult and expensive for any shorts to cover.

East-Description-243

Ya they work but the launch service that they NEED to successfully pull off the massive task of launching these satellites is raising safety concerns and is also their competitor and also already offering service DTC service! They will have voice and data before Asts even has minimal amount of satellites for any commercial service, mark my words. You all are in hopes and dreams and this point bro.

East-Description-243

Starlink already has DTC text and emergency through T-Mobile. ASTS still needs 20 more satellites deployed before beta service. They’ve only launched 6 satellites since sept 2023.

_ii_

I think you don’t yet have a firm grip on the terms: ~Private Bank~, ~FDIC Insured~, and ~Stock~. Private bank customers usually need to have more than 5 digit balance. To take advantage of private bank, you typically have someone do the transactions for you, otherwise it’s the same as any other brokerage account. FDIC is for bank deposits, not stocks. Stock is a claim to the company. You lose it by the company getting out of business. FDIC won’t help. Robinhood doesn’t buy the stock and keep it in their stockroom for you. Technically the cleaning house (DTC) “hold” the stock for you by updating their electronic records. Robinhood does some bookkeeping and communication with exchanges where actual trading took place. This is also how Robinhood makes money - selling your order flow.

East-Description-243

Starlink partnered with T Mobile and already has DTC text and emergency and voice/data coming soon. They are a year and a half in with service and ASTS hasn’t even launched the satellites to do any significant testing with ATT or Verizon.

skinnyjoints

Your AI summary is not correct. Current DTC is 2.8 days. I encourage you to do your own research especially when it only takes 10 seconds to verify. [Volume data](https://www.nasdaq.com/market-activity/stocks/bbgi/historical) [That volume data already used to calculate DTC for you](https://fintel.io/ss/us/bbgi)

Front_Requirement598

BBGI's short interest has seen recent significant increases, with ~113,000 shares shorted (around 13.3% of float) as of mid-December 2025, indicating growing bearish sentiment, although the Days to Cover (DTC) ratio is very low (near 0.0), suggesting high trading volume relative to short positions, making a traditional short squeeze less likely without a major shift in volume. END AI SUMMARY

justreadinplease

DTC was a flop because when they left local brick and mortar stores competitors moved in and suddenly all their old consumers couldn’t try on Nikes, but they could try on all these other brands. It’s not like Dick Sporting Goods or Hibbet Sports or whatever is going to leave their shelves bare. Nike tried to open a ton of stores, but trying to keep a store profitable when only selling one brand and also keeping a store up to Nike standards is hard. Nike is also not going to open a store in some small town where they can’t gross more than $5million in a location, but all those small podunk towns add up. Not being in those brand partners’ stores hurt - a death of a thousand cuts over time.

AntoniaFauci

Do you know why their DTC was such a flop? I didn’t follow it but on paper it seems like it would have been sensible. Consumers no longer caring where they buy or who fulfills the order, they just see a picture and want to click and receive the product. Nike owning the whole margin instead of splitting it with Foot Locker or Amazon. If I were given that pitch I’d say that sounds like as good a strategy as any. So what went wrong?

Full_Implement_2900

Nike’s DTC strategy is probably the biggest fiasco for a sportsbrand business wise the last 6-7 years. I remember reading about it in their reports back in 2018-2019

Nice-Beginning-7943

MEHA $0.23 DD, OS 16.25 million, Recent IPO from 11/5 at $8 a micro-cap company in the nutraceutical and wellness supplements space: • Established Legacy Brand: The company is built around Kirkman®, a trusted brand with over 75 years of history, sold in 35+ countries. It has a strong reputation for high-quality, hypoallergenic supplements, particularly in specialty areas like immunity, detox, and prenatal health. • Innovative Product Differentiation: The P2i™ by Kirkman® prenatal multivitamin stands out as the world’s first to fully align with International Federation of Gynecology and Obstetrics (FIGO) transparency standards for toxic chemicals and contaminants. It’s also the first to comply early with California’s SB 646 law (effective 2027), featuring QR codes linking to batch-specific test results for heavy metals, toxins, allergens, and more. This positions it as a leader in clean, transparent prenatal supplements amid growing consumer demand for safety and purity. https://finance.yahoo.com/news/functional-brands-inc-announces-p2i-130000920.html • Recent Growth Momentum: Q3 2025 results showed revenue up 21.4% year-over-year to $1.7M, driven by direct-to-consumer sales. Gross margins improved by 310 basis points to 57.8%, and the company swung to a profitable net income of $0.3M (vs. a loss last year). Over recent years, annual revenue has been stable around $6.5-6.8M with significant margin expansion (1,300 basis points). https://finance.yahoo.com/news/functional-brands-announces-third-quarter-210500607.html • Strategic Initiatives for Expansion: Partnerships like the one with Market Performance Group aim to accelerate eCommerce and digital growth for the Kirkman brand. Recent launches include a Skin, Beauty & Anti-Aging Bundle, and plans for direct Amazon management, a DTC telehealth platform (Tru2U), and Google-supported digital efforts to boost margins and reach. https://finance.yahoo.com/news/functional-brands-inc-launches-kirkmans-130000308.html • Nasdaq Listing and Visibility: Direct listing on Nasdaq in November 2025 enhances credibility, liquidity, and access to capital for “aggressive expansion” in the booming global health & wellness market. • Potential Undervaluation: With a market cap around $4M and enterprise value ~$5-6M, it trades at a low multiple relative to revenue (Price/Sales ~0.25). In a sector with strong tailwinds (rising demand for premium, science-backed supplements), successful execution on growth plans could offer significant upside for risk-tolerant investors.

Nice-Beginning-7943

MEHA $0.23 DD, OS:16.25 million, Recent IPO on 11/5 at $8 a micro-cap company in the nutraceutical and wellness supplements space: • Established Legacy Brand: The company is built around Kirkman®, a trusted brand with over 75 years of history, sold in 35+ countries. It has a strong reputation for high-quality, hypoallergenic supplements, particularly in specialty areas like immunity, detox, and prenatal health. • Innovative Product Differentiation: The P2i™ by Kirkman® prenatal multivitamin stands out as the world’s first to fully align with International Federation of Gynecology and Obstetrics (FIGO) transparency standards for toxic chemicals and contaminants. It’s also the first to comply early with California’s SB 646 law (effective 2027), featuring QR codes linking to batch-specific test results for heavy metals, toxins, allergens, and more. This positions it as a leader in clean, transparent prenatal supplements amid growing consumer demand for safety and purity. https://finance.yahoo.com/news/functional-brands-inc-announces-p2i-130000920.html • Recent Growth Momentum: Q3 2025 results showed revenue up 21.4% year-over-year to $1.7M, driven by direct-to-consumer sales. Gross margins improved by 310 basis points to 57.8%, and the company swung to a profitable net income of $0.3M (vs. a loss last year). Over recent years, annual revenue has been stable around $6.5-6.8M with significant margin expansion (1,300 basis points). https://finance.yahoo.com/news/functional-brands-announces-third-quarter-210500607.html • Strategic Initiatives for Expansion: Partnerships like the one with Market Performance Group aim to accelerate eCommerce and digital growth for the Kirkman brand. Recent launches include a Skin, Beauty & Anti-Aging Bundle, and plans for direct Amazon management, a DTC telehealth platform (Tru2U), and Google-supported digital efforts to boost margins and reach. https://finance.yahoo.com/news/functional-brands-inc-launches-kirkmans-130000308.html • Nasdaq Listing and Visibility: Direct listing on Nasdaq in November 2025 enhances credibility, liquidity, and access to capital for “aggressive expansion” in the booming global health & wellness market. • Potential Undervaluation: With a market cap around $4M and enterprise value ~$5-6M, it trades at a low multiple relative to revenue (Price/Sales ~0.25). In a sector with strong tailwinds (rising demand for premium, science-backed supplements), successful execution on growth plans could offer significant upside for risk-tolerant investors.

Nice-Beginning-7943

MEHA $0.23 DD, OS 16.25m, Recent IPO 11/5 @$8 a micro-cap company in the nutraceutical and wellness supplements space: • Established Legacy Brand: The company is built around Kirkman®, a trusted brand with over 75 years of history, sold in 35+ countries. It has a strong reputation for high-quality, hypoallergenic supplements, particularly in specialty areas like immunity, detox, and prenatal health. • Innovative Product Differentiation: The P2i™ by Kirkman® prenatal multivitamin stands out as the world’s first to fully align with International Federation of Gynecology and Obstetrics (FIGO) transparency standards for toxic chemicals and contaminants. It’s also the first to comply early with California’s SB 646 law (effective 2027), featuring QR codes linking to batch-specific test results for heavy metals, toxins, allergens, and more. This positions it as a leader in clean, transparent prenatal supplements amid growing consumer demand for safety and purity. • Recent Growth Momentum: Q3 2025 results showed revenue up 21.4% year-over-year to $1.7M, driven by direct-to-consumer sales. Gross margins improved by 310 basis points to 57.8%, and the company swung to a profitable net income of $0.3M (vs. a loss last year). Over recent years, annual revenue has been stable around $6.5-6.8M with significant margin expansion (1,300 basis points). • Strategic Initiatives for Expansion: Partnerships like the one with Market Performance Group aim to accelerate eCommerce and digital growth for the Kirkman brand. Recent launches include a Skin, Beauty & Anti-Aging Bundle, and plans for direct Amazon management, a DTC telehealth platform (Tru2U), and Google-supported digital efforts to boost margins and reach. • Nasdaq Listing and Visibility: Direct listing on Nasdaq in November 2025 enhances credibility, liquidity, and access to capital for “aggressive expansion” in the booming global health & wellness market. • Potential Undervaluation: With a market cap around $4M and enterprise value ~$5-6M, it trades at a low multiple relative to revenue (Price/Sales ~0.25). In a sector with strong tailwinds (rising demand for premium, science-backed supplements), successful execution on growth plans could offer significant upside for risk-tolerant investors.

Front_Requirement598

For AEHL (Antelope Enterprise Holdings), short interest has recently dropped significantly (down ~87% from mid-November to mid-December 2025), with ~28% of the float sold short as of mid-December, a high level indicating pessimism, but a very low days-to-cover (0.5-0.51 days), meaning short positions could be covered quickly, making a significant squeeze less likely despite the high percentage. DTC (Days to Cover) is extremely low, around 0.5 days, suggesting high liquidity for shorts to exit. END AI SUMMARY

Ok_Strain_1624

So literally no content or value other than DTC advertising. Can't even watch a 15 second video to giggle at now, just straight up corporate slop masquerading as AI slop.

mod_cat

I have most often seen the $50 charge is the same (between Fidelity and Schwab) for the same security. I think a couple times I have seen it where one didn't charge the $50 and the other did (but I could be wrong). I don't really understand how they decide. I have bought some foreign ADRs (with the symbol ending in F) that don't have that fee and others that do. In general the largest stocks don't have it but for the small companies that do it isn't consistent (some have the fee, some don't). I imagine there is some reason but never bothered to look until now... "Some foreign stocks traded on the OTC market aren’t eligible for clearing through the Depository Trust Company (DTC). This means that transferring these non-DTC-eligible securities incurs extra costs for Fidelity. In turn, they pass on these fees to cover the associated expenses." https://usefidelity.com/fidelity-charges-50-for-foreign-settlement-fee-heres-why/

Front_Requirement598

AI SUMMARY: As of late November 2025, Vivakor (VIVK) had significant short interest, with around 9.41 million shares sold short, representing roughly 11% of the float, a decrease from the prior month, resulting in a very low Days to Cover (DTC) around 0.3 to 0.4 days, indicating high trading volume relative to short positions, making it less prone to a typical short squeeze despite the high percentage.

Bornagainghostbuster

FLWS is the best current play right now, whether it squeezes or not is anyones guess. Most potential though by far. Can't believe this sub isn't all over 100% shorted and 5 DTC.

LCGfunding

Someone can do it with money of course like DTC drop shipping platform can compete like Temu. High prices will force people to go temu. given opporttemp Temu will cut a share of amzn incrementally. Its the consumer base, prime/speed of shipping that made the difference with loyal customers.

Difficult_Winner_777

Tiny float doesn’t mean squeeze by itself. SI is ~4% with 0.10 DTC, and CMCT is actively issuing common for preferred redemptions per recent 8-Ks. Pops are possible, but this isn’t a trapped-short setup or “next SMX.”

Scquwer

Overall good week $VIPZ, looks like the legacy seller is out, they were pushing hard since the beginning of the month. Looks like the last trench, maybe went in early this week but now it’s stable and now nicely starting to climb back up. DTC hasn’t changed for a long time no shenanigans. Float pretty locked, just basic OTC market maker Algo’s doing their thing on lower volume, but once there’s pressure should be nice. Looking forward to what Les and team can accomplish in 2026!

_hiddenscout

Company basically has had declining revenue every quarter since May 2023.  Also negative EPS growth.  Seems like a lot of the investment and how heavy they went into DTC and cutting back on innovation really hurt them. 

Pretty_Apartment3511

0.1 days to cover. Good short interest and low float, however due to the high trading volume and the fact their DTC are so low makes it difficult. Still possible, just difficult.

OutlandishnessUsed24

Thats not true, the long term thesis is just to help elevate people from bankruptcy risk. Again, for 10000000 time, this company is already priced at bankruptcy so unless it DOES go bankrupt its only up from here. My DD is evolving all day as I get deeper. I have been following this stock all week but next week is my timing theory on shorts covering with no ammo for supply of share (all shares are held internally or by family, no convertable debt, no risk to share issuance, and nore more shares to short) Besides my 5 points below, the real critical piece is section 3 on this DD. You dont have to listen to me, if I am wrong we will see this week on the 1st half of my thesis. Come back here on Thursday/Friday :) 1.    94.82% of Float is Short — Near-total saturation of available shares 2.    TRUE Days to Cover: 53.7 days — The reported 4.14 DTC is misleading (see Section 2) 3.    Borrow inventory collapsed 84% — From 3.1M to 500K and has NOT recovered 4.    FINRA Exempt shorting spiked 26x on Dec 10 — 7.4-sigma event, statistically significant MM intervention 5.    Shorts ADDED 200K shares during Dec 9-12 — They're digging deeper, not covering Section 3 on my 13 page DD on my local drive is particularly interesting to me. Do what you want with my advice, it makes no difference to me https://preview.redd.it/cpwi8c2p547g1.png?width=1920&format=png&auto=webp&s=f940c8f250cacd7b098c0d817f8d66fb35f52c2c #

OutlandishnessUsed24

This is the right call. FLWS has a much cleaner setup than SGBX. Here's the data as of this weekend: **Borrow availability:** * Started last week at 3.2M * Thursday morning: dropped to 600K after shorts borrowed 2.6M to attack * Saturday overnight: dropped again to **500K** * Someone borrowed 100K shares on a weekend ahead of Monday **The imbalance:** * 9.4M shares short (FINRA) * 500K available to borrow * That's **18.8x imbalance** **What happened Thursday:** Shorts threw 2.5M shares at it in a concentrated attack and only got a 9% drop. Price held $3.90 support. They used 84% of their ammo and barely moved it. **What's different from SGBX:** * SGBX float expanded (dilution), FLWS hasn't diluted * SGBX insiders selling, FLWS insiders just got granted 133K shares (accumulating) * SGBX DTC < 1 day, FLWS has almost no shares available to cover with * SGBX no catalyst, FLWS just hired AI-focused CIO Dec 8 (stock popped 30%) **The part people are missing:** Even without the squeeze, FLWS is a $1.7B revenue company trading at $285M market cap (0.17x sales). That's priced for bankruptcy - but they're not going bankrupt. $93M EBITDA last year, new leadership team (first non-family CEO ever), and the McCann family owns \~42% and isn't selling. So the way I see it: * Squeeze works → big win * Squeeze doesn't work → I own a $2B revenue company at all-time lows SGBX doesn't have that floor. Sources: [Fintel](https://fintel.io/ss/us/flws) | [iBorrowDesk](https://iborrowdesk.com/report/FLWS)

ryzetard

if it has some strong earnings this year... volume keeps dropping, short interest stays high so DTC increases, insiders still keep the shares so i dont think they are very afraid of being deficient at the moment and low float.

ryzetard

depending on which source you trust the most: [https://fintel.io/ss/us/sgbx](https://fintel.io/ss/us/sgbx) [https://www.marketwatch.com/investing/stock/sgbx](https://www.marketwatch.com/investing/stock/sgbx) (btw seems they diluted, their previous outstanding shares were 5.6 million approximately as per their latest SEC filing - not a surprise cuz they are doing really bad recently) [https://finviz.com/quote.ashx?t=SGBX&p=d](https://finviz.com/quote.ashx?t=SGBX&p=d) [https://finance.yahoo.com/quote/SGBX/key-statistics/](https://finance.yahoo.com/quote/SGBX/key-statistics/) Float is everywhere more or less in line, short interest is in like 10-20% territory only, volume is high so DTC is less than 1 day on average. no way it can run

ryzetard

ok i worded it very poorly, apologies I didnt want to say that exactly you still promote bynd, i meant that sgbx is becoming bynd 2.0 and i have no clue why sgbx is still even mentioned. most sites confirm the float expanded which is in line with insiders and insitutions selling their holdings, true SI is lower, DTC is like 0.1-1 tops, no catalysts on the horizon to attract more people and fundamentally its just bad, even for penny standards. the only indicator left are borrowing costs but that just might be due to the recent run making lenders lose a lot and insuring themselves from it preemptively

ryzetard

so whats your opinion on it? the gamble is that their earnings may be seeing an upside since the last year due to september news - if they landed some upfront payments from these deals so a catalayst MIGHT happen - or not. The rest is as I described, not that big of a public float, majority locked by insiders/private placements, big SI, only the days to cover could be at least 2 or 3 to make it a very good squeeze candidate (still could happen, it would just be short lived if low DTC).

ryzetard

I think 4.3 is a good support level as well, keeps rebounding there. It will pop with another catalyst i think if this stock retains both high short interest and DTC. They wont go bankrupt any time soon and are undergoing some changes so i intend to keep it for some time, no daytrading or timing the market.

ryzetard

FLWS has just appointed a new veteran CIO, new CEO this year and hopefully there are some good news coming from the shareholder meeting regarding their new strategies and tech integration. Aside from that it has one of the stronger short squeeze setups due to both high SI (at least 30% or even up to 80% depending on the sources) and very high DTC (at least a week) values which are the most important factors , uavs has nothing going for it just like CVU - i dont understand these two tickers getting hyped

Which_Perspective871

You just buy or sell on vibes w/ shorts & DTC? I made a composite indicator on tradingview which is 9 indicators put together. I use it to screen 4hr, 1d, & a custom 3d timeframe. When it signals (meaning all indicators give it a 👍) it has a high win rate.

Which_Perspective871

You just buy or sell on vibes w/ shorts & DTC? I made a composite indicator on tradingview which is 9 indicators put together. I use it to screen 4hr, 1d, & a custom 3d timeframe. When it signals (meaning all indicators give it a 👍) it has a high win rate.

ryzetard

i asked about SGBX and will do so again - what are you basing your float on when institutionals were selling, squeeze already happened, DTC swings between 0.1-0.5 and SI dropped as per nasdaq. what do you even expect there?

Sea_Conversation_440

Sorry did i mention BYND here like to compare DFLI to it? Short squeezes existed long before BYND, and the DD I posted was only about DFLI’s actual data, not a meme comparison..? If the short interest and DTC didn’t change dramatically, I wouldn’t have bothered. Its data im sharing so calm yourself, its called a DD buddy.

Sea_Conversation_440

DFLI Short Squeeze (Heres the current short data) * Short interest: **15.4M shares** * Days to Cover jumped: **3.09** * Off-exchange (dark pool) ratio now: **55%** * Borrow availability staying low * RS deadline approaching → increased volatility * Lower volume + rising DTC = shorts becoming more trapped Not saying it *will* squeeze, but all we need is more volume to get this over a dollar. Dfli may announce news within these 3 days as well. The shorts are basically trapped with this setup.

ryzetard

Question is - do you think a stock shorted at 95% with over a month worth of DTC would not start covering after an over 25% upside with a signifcant volume increase day to day? That free float is kinda sketchy, but it can still run i think.

jarstiffler

I did a DD on FLWS yesterday. New CIO announced yesterday; has experience with Amazon, Bed Bath Beyond, etc.. 95% short float. 35 DTC. Not super expensive to borrow yet, but with volume/pressure from retail, that will change. I like the set up.

jarstiffler

It’s ready. 35 DTC, 95% short.

jarstiffler

35 DTC now...

scarletrose4444

TLDR: I'm in a similar situation in that I want to sell my DTC (South Denver, Co) house, rent an apartment and potentially invest the equity until I either move in with a partner or buy something else without the highest level of work (approx 6 months, could do it for longer if it seems smart). Single mother, 2 kids, approx 50/50 with Dad but I do the heavy lifting when it comes to school costs and extracurriculars. The yard and maintenance is killing me. I have founded a startup and would prefer not to have the cost of maintenance, insurance, property taxes, hoa ($1800p.a.) etc over my head. Thinking about selling and investing the ~$600k take home, while I rent something smaller and more manageable so I can use my spare time developing my business. I've been reading this and other similar posts and most suggest six months is too short a time to be investing, and too risky in this climate. My thoughts are to park the money but I don't want to be foolish and too risk averse if there is an intelligent play out there that I should be considering. I appreciate any advice.

Bojangles315

That is incorrect lmfao. They are recorded in book value, yes. in street name... at the DTCC, not the DTC. that is, in the broker dealers name. they are owned by the brokerage firm with you as a beneficial owner. not even going to explain an Omnibus or full disclosure basis. the company does not have your name, only the firm. the accounts are numbered, and the people are numbered. proxies and such are delivered by the firm on behalf of the corporation SIPC only kicks in for liquidation of a firm. lost/misplaced securities are handled during the count. they don't involve the SIPC whatsoever. once the count is done, which is a FINRA required thing for firms, it is taken against the firms net capital requirements. 25% at 7 days, 50% at 14, 75% at 21, and 100% at 28 days. the number of days is based on buy in/sell out requirements. this is derived from the clearing requirements. t+4 for normal transactions, all the way up to T+35 or even when issued transactions. Fidelity bonds would then come into play in the event of fraud. Fidelty bond requirements are based on net capital requirements. there is no such thing as a series 1. a series 4 is an options principal and does not apply here. a series 3 is a futures/commodities exam and would not apply here, a series 2 was a non registered exam and discontinued and would not apply here. What I have, series 7. general securities registered rep exam. series 99 is an operations professional registered rep exam which deals with this, a series 24 is a registered principals exam which deals with exactly this and net capital requirements for managing a firm, and a series 66 is a registered rep securities states law exam.

serendipitySR

Starlink - trillion dollars market DTC- trillion dollars market (after Echostar acquisition). Space data center - in development. Starship will make it happen. Need anything else? Starshield, Artemis, moon base, space tourism

Alarmed_Sell_1583

The reported float includes insiders, preferred structures, and locked blocks. Once you remove what doesn’t circulate, the tradable supply tightens to roughly 500k to 900k and that is the liquidity the market actually prices. DTC follows that scarcity, not the headline float. I am here to clarify the structure, not to shift your conviction. The market will speak for both of us!